Compare THRM & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | THRM | LMAT |
|---|---|---|
| Founded | 1991 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 1996 | 2006 |
| Metric | THRM | LMAT |
|---|---|---|
| Price | $31.82 | $84.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $48.00 | ★ $107.00 |
| AVG Volume (30 Days) | ★ 2.3M | 210.2K |
| Earning Date | 10-22-2026 | 11-04-2026 |
| Dividend Yield | ★ 7.24% | 1.19% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | 0.19 | ★ 1.42 |
| Revenue | ★ $554,979,000.00 | $249,602,000.00 |
| Revenue This Year | $15.24 | $10.79 |
| Revenue Next Year | $43.30 | $9.55 |
| P/E Ratio | $151.11 | ★ $59.36 |
| Revenue Growth | ★ 50.16 | 13.53 |
| 52 Week Low | $25.31 | $78.22 |
| 52 Week High | $48.35 | $118.01 |
| Indicator | THRM | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 49.19 | 57.02 |
| Support Level | $28.44 | $83.27 |
| Resistance Level | $32.11 | $88.73 |
| Average True Range (ATR) | 1.79 | 2.02 |
| MACD | 0.29 | 0.39 |
| Stochastic Oscillator | 87.65 | 79.60 |
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.